An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity
Journal article
![Thumbnail](/fhi-xmlui/bitstream/handle/11250/2359760/Norheim_2015_Ano.pdf.jpg?sequence=6&isAllowed=y)
View/ Open
Date
2015Metadata
Show full item recordCollections
- Artikler [5061]
- Publikasjoner fra CRIStin FHI [7536]
Description
-